These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36606388)

  • 1. Claudin-3 is a novel intestinal integrity marker in patients with alopecia areata: Correlation with the disease severity.
    Rafik D; Younis I; Atef R; Eid H
    J Cosmet Dermatol; 2023 Apr; 22(4):1377-1381. PubMed ID: 36606388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-3 - a new intestinal integrity marker in patients with psoriasis: association with disease severity.
    Sikora M; Chrabąszcz M; Waśkiel-Burnat A; Rakowska A; Olszewska M; Rudnicka L
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1907-1912. PubMed ID: 31120609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Claudin- 3 as a biomarker of gut-skin axis integrity in patients with psoriasis.
    Mahran A; Hosni AM; Farag NG; Elkhawaga AA; Mageed AAA
    Arch Dermatol Res; 2024 Jul; 316(7):476. PubMed ID: 39023797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin as a novel biomarker of disease severity in alopecia areata.
    Stochmal A; Waśkiel-Burnat A; Chrostowska S; Zaremba M; Rakowska A; Czuwara J; Rudnicka L
    Sci Rep; 2021 Jul; 11(1):13809. PubMed ID: 34226603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal barrier integrity in patients with plaque psoriasis.
    Sikora M; Chrabąszcz M; Maciejewski C; Zaremba M; Waśkiel A; Olszewska M; Rudnicka L
    J Dermatol; 2018 Dec; 45(12):1468-1470. PubMed ID: 30222202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the serum C-reactive protein-albumin ratio and its relationship with disease severity IN alopecia areata: A prospective case-control study.
    Kalaycı BN; Balta İ
    J Cosmet Dermatol; 2022 Dec; 21(12):7194-7199. PubMed ID: 36225083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and tissue angiotensin-converting enzyme in patients with alopecia areata.
    Fahim S; Montazer F; Tohidinik HR; Naraghi ZS; Abedini R; Nasimi M; Ghandi N
    Indian J Dermatol Venereol Leprol; 2019; 85(3):295-299. PubMed ID: 29582789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin-2 and insulin as new biomarkers of alopecia areata.
    Waśkiel-Burnat A; Niemczyk A; Chmielińska P; Muszel M; Zaremba M; Rakowska A; Olszewska M; Rudnicka L
    PLoS One; 2022; 17(5):e0268086. PubMed ID: 35639706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on Serum Vitamin D in Alopecia Areata Patients.
    Marahatta S; Agrawal S; Khan S
    J Nepal Health Res Counc; 2019 Apr; 17(1):21-25. PubMed ID: 31110371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a link between alopecia areata and gut?
    Hacınecipoğlu F; Gönül M; Özdemir Ş; Demir ÖF
    J Cosmet Dermatol; 2022 Nov; 21(11):6049-6055. PubMed ID: 35579378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia Areata and Thyroid Dysfunction Association- A Study from Eastern Nepal.
    Marahatta S; Agrawal S; Mehata KD
    Kathmandu Univ Med J (KUMJ); 2018; 16(62):161-165. PubMed ID: 30636758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
    Elmaadawy E; Elgarhy LH; Shareef M
    J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA copy number as a diagnostic marker and indicator of degree of severity in alopecia areata.
    Shehata WA; Hammam MA; Abdo A; Tayel N; Abdelsattar S
    J Immunoassay Immunochem; 2023 May; 44(3):256-268. PubMed ID: 36681933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD117 and platelet-derived growth factor receptor α in patients with alopecia areata.
    Mohanan S; Sylvia MT; Carounanidy U; Bhat RV
    Indian J Dermatol Venereol Leprol; 2020; 86(6):643-648. PubMed ID: 32461384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.
    Wang Z; Wang A; Gong Z; Biviano I; Liu H; Hu J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):410-416. PubMed ID: 31053499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H; Maher R; Negm D
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and antioxidant markers in patients with alopecia areata: A comparative cross-sectional study.
    Shakoei S; Mirmiranpoor H; Nakhjavani M; Nasimi M; Bakhshi G; Azizpour A
    Indian J Dermatol Venereol Leprol; 2023; 89(3):411-415. PubMed ID: 35962507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata.
    Aşkın Ö; Yücesoy SN; Coşkun E; Engin B; Serdaroğlu S
    An Bras Dermatol; 2021; 96(5):551-557. PubMed ID: 34281739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase activity: A novel potential biomarker for predicting Alopecia areata.
    Taskin S; Celik H; Cakirca G; Manav V; Taskin A
    J Cosmet Dermatol; 2022 Dec; 21(12):7075-7080. PubMed ID: 36093562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.